(Q35683359)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Ping Yang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

182-190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

Alpha-1 antitrypsin deficiency

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Alpha1-antitrypsin deficiency: biological answers to clinical questions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

The alpha 1-antitrypsin gene and its deficiency states

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Distribution of alpha 1-antitrypsin variants in a US white population

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Population Genetics of Alpha-1-Antitrypsin Polymorphism in US Whites, US Blacks and African Blacks

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Outcome of liver disease associated with alpha 1 antitrypsin deficiency (PiZ). Implications for genetic counselling and antenatal diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

The natural history of liver disease in alpha 1-antitrypsin deficient children

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Recent pulmonary observations in alpha 1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C, and other hepatic problems

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Lack of increase in heterozygous α1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Smoking, lung function, and alpha 1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Alpha-1-antitrypsin (AAT) deposits in gall bladder adenocarcinoma and liver in partial AAT deficiency (Pi SZ phenotype)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Alpha-1-antitrypsin phenotypes in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Airways obstruction and the risk for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Primary structure of human neutrophil elastase

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

The role of neutrophil elastase in acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Proteolytic cleavage of granulocyte colony‐stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony‐stimulating factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Neutrophil elastase: alpha-1-proteinase inhibitor complex in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Enhancer function of a 53-bp repetitive element in the 5' flanking region of the human neutrophil elastase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Inhibition of neutrophil elastase suppresses the development of skin tumors in hairless mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Neutrophil elastase inhibitor reduces hepatic metastases induced by ischaemia-reperfusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Tumor neutrophil elastase is closely associated with the direct extension of non-small cell lung cancer into the aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Free-form neutrophil elastase is an independent marker predicting recurrence in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

TNF-R1 signaling: a beautiful pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Gene therapy approaches for inherited and acquired lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

Gene therapy for lung inflammatory diseases: not so far away?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901414-7

7 January 2021

10.1016/S1470-2045(04)01414-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15003202%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference